IL6 and COVID-19: Importantly, elevated IL-6 (>70 pg/ml) levels as well as other cytokines (after multivariate adjustment for sex, age, ethnicity, comorbidities) were associated with reduced survival (HR 2.47, p < 0.0001) of patients hospitalized for COVID-19 in New York (USA) (151).